Building momentum: recent milestones at Obulytix

Obulytix has had an exciting start to the year, marked by important milestones and strengthening the contribution to the fight against antimicrobial resistance. Obulytix joined the END2AMR consortium, a new Innovative Health Initiative (IHI)-supported collaboration focused on accelerating solutions against drug-resistant bacterial infections through cross-sector innovation. Most recently,…